breast cancer

Lilly's oral SERD Ember counts on Verzenio to broaden its glow

Lilly's imlunestrant monotherapy only mounted a PFS benefit in ESR1-mutated tumors, while its pairing with Verzenio moved the needle in a wider group.

Angus Liu Dec 11, 2024 8:15am

pathologist looking at samples through a microscope

PreciseDx's breast tumor pathology AI measures up to DNA testing

Dec 6, 2024 9:00am

GE HealthCare debuts AI-powered, zero-click mammography system

Dec 2, 2024 9:30am

GE HealthCare inks collab with RadNet in mammography AI

Nov 12, 2024 10:10am

Siemens Healthineers scores FDA nod for 5-second, 3D mammography

Oct 3, 2024 11:30am

Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

Genentech pays $850M upfront for Regor's CDK inhibitors

Sep 30, 2024 5:30am